Laninamivir

DB12791InvestigationalSmall molecule

Laninamivir has been used in trials studying the treatment of Influenza.

Chemical structure of Laninamivir
Mechanism
Curator reviewed
Formula / weight
C13H22N4O7 · 346.3364 g/mol (avg)
Code names
R-125489

Resolves to

Compound
UNIIB408IW3GL5CAS203120-17-6ChEMBLCHEMBL466246PubChem502272
Clinical / RWD
ATCJ05AH04
Structure
InChIKeyQNRRHYPPQFELSF-CNYIRLTGSA-NSMILES[H][C@]1(OC(=C[C@H](NC(N)=N)[C@H]1NC(C)=O)C(O)=O)[C@H](OC)[C@H](O)CO
Targets
P06818NAP27907NA

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
14Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 14 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Laninamivir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In